Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-05-29
2007-05-29
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S326000
Reexamination Certificate
active
11095870
ABSTRACT:
Methods for modulating TRIP-Br function and activity in a proliferating cell are provided, as well as methods for treating a proliferative disorder by modulating TRIP-Br function in a proliferating cell.
REFERENCES:
patent: 6372720 (2002-04-01), Longmuir et al.
patent: 2003/0108597 (2003-06-01), Chancellor et al.
Sim, et al., Journal of American Society of Nephrology, 2002, 13, 33A.
Hsu, et al., The EMBO Journal, 2001, 20, 2273-2285.
Aasland, R., et al. The PHD finger: Implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci. 1995. pp. 56-59. vol. 20.
Bandera, L.R., et al. Apoptosis induced in mammalian cells by peptides that functionally antagonize the Rb-regulated E2F transcription factor. Nature Biotech. 1997. pp. 896-901. vol. 15.
Capili, A.D., et al. Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domains. EMBO. 2001. pp. 165-177. vol. 20.
Derossi, D., et al. The third helix of the Antennapedia Homeodomain translocates through biological membranes. J. Biol. Chem. 1994. pp. 10444-10459. vol. 269.
Diffley, J.F. and Labib, K. The chromosome replication cycle. J. Cell Sci. 2002. pp. 869-872. vol. 115.
Dyson, N. The regulation of E2F by pRB-family proteins. Genes & Development, 1998. pp. 2245-2262. vol. 12.
Elbashir, et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster. EMBO J. 2001. pp. 6877-6888. vol. 20.
Frick, D.N. and Richardson, C.C. DNA primases. Annu Rev Biochem. 2001. pp. 39-80 vol. 70.
Harbour, J.W., et al. Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1. Cell. 1999. pp. 859-869. vol. 98.
Harbour, J.W. and Dean, D.C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 2000. pp. 2393-2409. vol. 14.
Haynes, S., et al. The bromodomain: a conserved sequences found in human, Drosophila and yeast protein. Nucl Acids Res. 1992. pp. 2603. vol. 20.
Helin, K. Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev. 1998. pp. 28-35. vol. 8.
Hsu, S.I.H., et al. TRIP-Br: A novel family of PHD zinc finger and bromodomain interacting proteins that regulate the transcriptional activity of E2F-1/DP-1. EMBO J. 2001. pp. 2273-2285. vol. 20.
Kalkhoven, E., et al. The PHD type zinc finger is an integral part of the CBP acetyltransferase domain. Mol Cell Biol. 2002. pp. 1961-1970. vol. 22.
Keyomarsi, K. and Herliczek, T.W. Prog Cell Cycle Res. 1997. pp. 171-191. vol. 3.
Kim, S.-S., et al. A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc Natl Acad Sci USA. 1996. pp. 15299-15304. vol. 93.
Koepp, D.M., et al. How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell. 1999. pp. 431-434. vol. 97.
Koepp, D.M., et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science. 2001. pp. 177. vol. 294.
Koken, M.H.M., et al. A C4HC3 zinc finger motif. C R Acad Sci III. 1995. pp. 733-739. vol. 318.
Lam, E., et al. DP and E2F proteins: coordinating transcription with cell cycle progression. Curr Opin Cell Biol. 1994. pp. 859-866. vol. 6.
LE Douarin, B., et al. A possible involvement of TIF1a and TIF1b in the epigenetic control of transcription by nuclear receptors. EMBO J. 1996. pp. 6701-6715. vol. 15.
Lomazzi, M., et al. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry. Nat Gen. 2002. pp. 190-194. vol. 31.
Marmorstein, R.a.B., S.L. Structure and function of bromodomains in chromatin-regulating complexes. Gene. 2001. pp. 1-9. vol. 272.
Martin, K., et al. ,Stimulation of E2F-1/DP-1 transcriptional activity by MDM oncoprotein. Nature. 1995. pp. 691-694. vol. 375.
McGarry, T.J. and Kirschner, M.W. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell. 1998. pp. 1043-1053. vol. 93.
Miller, G.P. and Benkovic, S.J. Stretching exercises-flexibility in dihydrofolate reductase catalysis. Chem Biol. 1998. pp. 105-113. vol. 5.
Moosmann, P. et al. Transcriptional repression by RING finger protein TIF1b that interacts with the KRAB repressor domain of KOX1. Nucl Acids Res. 1996. pp. 4859-4867. vol. 24.
Muller, H., et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 2001. pp. 267-285. vol. 15.
Nahle, Z., et al. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol. 2002. pp. 859-864. vol. 11.
Ohtsubo. M. and Roberts, J.M. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science. 1993. pp. 1908-1912. vol. 259.
Ohtsubo, M., et al. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol. 1995. pp. 2612-2624. vol. 15.
Patel, T., et al. The role of proteases during apoptosis. FASEB. 1996. pp. 587-597. vol. 10.
Philips, A.C. and Vousden, K.H. E2F-1 induced apoptosis. Apoptosis. 2001. pp. 173-182. vol. 6.
Rajagopalan, H., et al. Inactivation of hCDC4 can cause chromosomal instability. Nature. 2004. pp. 77-81. vol. 428.
Rosenblatt, J., et al. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc. Natl Acad Sci USA. 1992. pp. 2824-2828.. vol. 89.
Roy, L.M., et al. Activation of p34cdc2 kinase by cyclin A. J Cell Biol. 1991. pp. 507-514. vol. 113.
Santiago, F.S., et al. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med. 1999. pp. 1264-1269. vol. 5.
Schultz, D.C., et al. Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unti that recruits a novel isoform of the Mi-2a subunit of NuRD. Genes Dev. 2001. pp. 428-433. vol. 15.
Sherr, C.J. Mammalian G1 Cyclings. Cell. 1993. pp. 1059-1065. vol. 73.
Sherr, C.J. and Roberts, J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999. pp. 1501-1512. vol. 13.
Smits, V.A. and Medema, R.H. Checking out the G(2)/M transition. Biochim Biophys Acta. 2001. pp. 1-12. vol. 1519.
Spruck, C.H., et al. Deregulated cyclin E induces chromosome instability. Nature. 1999. pp. 297-300. vol. 401.
Sugimoto, M., et al. Regulation of CDK4 activity by a novel CDK-binding protein, p34SEI1. Genes Dev. 1999. pp. 3027-3033. vol. 13.
Tanaka, S. and Diffley, J.F.X. Deregulated G1-cyclin expression induces genomic instability by preventing efficient pre-RC formation. Genes Dev. 2002. pp. 2639-2649. vol. 16.
Trimarchi, J.M. and Lees, J.A. Reviews: Sibling rivalry in the E2F Family. Nat Rev Mol Cell Biol. 2002. pp. 11-20. vol. 3.
Warbrick, E. The puzzle of PCNA's many partners. Bioessays. 2000. pp. 997-1006. vol. 22.
Wohlschlegel, J.A., et al. Inhibition of eukaryotic DNA replication by geminin binding to Cdtl. Science. 2000. pp. 2309-2312. vol. 290.
Zeng, L. and Zhou, M.-M. Bromodomain: an Acetyl-lysine binding domain. FEBS Letters. 2002. pp. 124-128. vol. 513(1).
Sim, K.G., et al. TRIP-Br Links E2F to Novel Functions in the Regulation of Cyclin E Expression during Cell Cycle Progression and in the Maintenance of Genomic Stability. Cell Cycle. Oct. 2004. pp. 1296-1304. vol. 3, Issue 10. Epub Oct. 6, 2004.
Gudibande Satyanarayana R.
Gupta Anish
Klarquist & Sparkman, LLP
National University of Singapore
LandOfFree
Modulation of TRIP-Br function and method of treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of TRIP-Br function and method of treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of TRIP-Br function and method of treating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3773937